3Chow AK,Cena J,Schulz R.Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature〔J〕.Br J Pharmacol,2007;152(2):189-205.
4Kuge Y,Takai N,Ishino S,et al.Distribution profiles of membrane type-1 matrix metalloproteinase (MT1-MMP),matrix metalloproteinase-(MMP-2) and cyclooxygenase-2 (COX-2) in rabbit atherosclerosis:comparison with plaque instability analysis〔J〕.Biol Pharm Bull,2007;30(9):1634-40.
5Zouridakis E,Avanzas P,Arroyo-Espliguero R,et al.Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris〔J〕.Circulation,2004;110(13):1747-53.
6Manginas A,Bei E,Chaidaroglou A,et al.Peripheral levels of matrix metalloproteinase-9,interleukin-6,and C-reactive protein are elevated in patients with acute coronary syndromes:Correlations with serum troponinI〔J〕.Clin Cardiol,2005;28(4):182-6.
7Funayama H,Ishikawa SE,Kubo N,et al.Increases in interleukin-6 and matrix metalloproteinase-9 in the infarct-related coronary artery of acutemyocardial in farction〔J〕.Circ J,2004;68(5):451-4.
8Inokubo Y,Hanada H,Ishizaka H,et al.Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome〔J〕.Am Heart J,2001;141(2):211-7.
9Uzui H,Harpf A,Liu M,et al.Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque:role of activated macrophages and inflammatory cytokines〔J〕.Circulation,2002;106:3024-30.
10Loftus IM,Naylor AR,Goodall S.Increased matrix metalloproeinase-9 activity in unstable carotid plaque.A potential role on acute plaque disruption〔J〕.Stroke,2003;31(1):40-7.
二级参考文献7
1[1]Dol F, Martin G, Staels B, et al. Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression and macrophage accumulation in apolipoprotein E-deficient mice. J Cardiovasc Pharmacol,2001,38: 395- 405.
2[2]Tsikouris J P, Cox C D. Pharmacologic blockade of the renin-angiotensin system: vascular benefits beyond commonly understood pharmacologic actions. Pharmacotherapy, 2003,23:1141-1152.
3[3]Reno C, Boykiw R, Luisa M, et al. Temporal alterations in mRNA levels for proteinases and inhibitors and their potential regulators in the healing medial collateral ligament. Biochem Biophys Res Commun, 1998,252:757-763.
4[4]Arroyo L H, Lee R T. Mechanisms of plaque rupture:mechanical and biologic interaction. Cardiovas Res,1999,41:369-375.
5[5]Uzui H, Harpf A, Liu M, et al. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines. Circulation, 2002 , 106:3024-3030.
6[7]Miyazaki M, Takai S. Involvement of angiotensin Ⅱ in development of atherosclerosis. Nippon Rinsho, 2002,60:1904-1910.
4Virmani R,Burke A P,Farb A,et al.Pathology of the vulnerable plaque[J].J Am Coll Cardiol,2006,47(8):C13-C18.
5Kolodgie F D,Burke A P,Farb A,et al.Differential accumulation of proteoglycans and hyaluronan in culprit lesions:Insights into plaque erosion[J].Arterioscler Thromb Vasc Biol,2002,22(10):1642-1648.
6Mallat Z,Tedgui A.Current perspective on the role of apoptosis in atherothrombotic disease[J].Circulation,2001,88(10):998-1003.
7Durand E,Scoazec A,Lafont A,et al.In vivo induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation:A clue to the understanding of the mechanisms of thrombotic plaque erosion[J].Circulation,2004,109(21):2503-2506.
8Bakker S J,Gans R O.About the role of shear stress in atherogenesis[J].Cardiovascular Research,2000,45(2):270-272.
9Fukumoto Y,Hiro T,Fujii T,et al.Localized elevation of shear stress is related to coronary plaque rupture[J].J Am Coll Cardiol,2008,51(6):645-650.
10Chatzizisis Y S,Coskun A U,Jonas M,et al.Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling:Molecular,Cellular,and Vascular behavior[J].J Am Coll Cardiol,2007,49(25):2379-2393.
